Three corporate behemoths have hatched a plan to step in to the American healthcare market, with the aim of “improving employee satisfaction and reducing costs.”
Digital colossus Amazon has teamed up with financier JPMorgan Chase and sprawling conglomerate Berkshire Hathaway to create “an independent company that is free from profit-making incentives and constraints.”
The firms will focus on “technology solutions that will provide US employees and their families with simplified, high-quality and transparent healthcare at a reasonable cost.”
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze